"Company","Parent Company","Penalty Amount","Subtraction From Penalty","Penalty Amount Adjusted For Eliminating Multiple Counting","Penalty Year","Penalty Date","Offense Group","Primary Offense","Secondary Offense","Description","Level of Government","Action Type","Agency","Civil/Criminal","Prosecution Agreement","Court","Case ID","Private Litigation Case Title","Lawsuit Resolution","Facility State","City","Address","Zip","NAICS Code","NAICS Translation","HQ Country of Parent","HQ State of Parent","Ownership Structure","Parent Company Stock Ticker","Major Industry of Parent","Specific Industry of Parent","Info Source","Notes"
"U.S. Renal Care","U.S. Renal Care","$7,300,000","$0","$7,300,000","2013","20130521","government-contracting-related offenses","False Claims Act and related","","U.S. Renal Care agreed to pay $7.3 million to resolve allegations that Dialysis Corporation of America, which it acquired in 2010, violated the False Claims Act by submitting false claims to the Medicare program for more Epogen than was actually administered to dialysis patients at DCA facilities.","federal","agency action","Justice Department Civil Division","civil","","","","","","","","","","","","USA","Texas","privately held","","healthcare services","dialysis services","https://www.justice.gov/opa/pr/us-renal-care-pay-73-million-resolve-false-claims-act-allegations",""
